Skip to main content
Premium Trial:

Request an Annual Quote

Grail Gets NY State Department of Health Approval for Galleri Multicancer Test

NEW YORK — Grail said on Monday that its Galleri blood-based multicancer early detection test has been approved by the New York State Department of Health.

With the approval, the test may now be offered by prescription in New York state as a complement to existing single-cancer screening tests, the Menlo Park, California-based company said.

"This approval represents a significant milestone in bringing Galleri to patients and healthcare providers across the US, and continued progress toward our mission to detect cancer early, when it can be cured," Josh Ofman, Grail's chief medical officer, said in a statement.

Galleri is designed to detect more than 50 cancer types through a routine blood draw and, when a cancer signal is detected, predict its origin. Grail launched the test in June in conjunction with the release of initial efficacy data from an ongoing prospective interventional study of the test.

Shortly thereafter, Grail was acquired by Illumina, which spun the company out in 2016, in a transaction that remains under scrutiny by the US Federal Trade Commission, as well as European regulators.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.